AC
IRMD icon

Amici Capital’s iRadimed IRMD Stock Holding History

Amici Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,000
Closed -$255K – 73
2016
Q3 		$255K Hold
15,000
– – 0.07% 83
2016
Q2 		$326K Buy
+15,000
New +$270K 0.06% 105

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amici Capital's IRMD Position: Q4 2016 in Review

Amici Capital sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 15,000 shares — an estimated $255K sold.

Amici Capital first reported a position in IRMD in Q2 2016 and held it in 2 quarters. The position peaked at $326K in Q2 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • Amici Capital reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • Amici Capital sold 15,000 iRadimed shares in Q4 2016, an estimated $255K.
  • Amici Capital first reported a position in iRadimed in Q2 2016 and held it in 2 quarters.
  • Amici Capital's iRadimed position peaked at $326K in Q2 2016.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.